Friday, November 07, 2025 9:50:58 AM
manibiotech,
You have seen what the bad actors did with the share price without emphasis on disclosure that manufacturing and product release hurdles had to be overcome and that there was no known timeline for that. This was hinted at of course in the mandatory disclosures which is all that is required by law. Mr. Neil Woodford called that a “bump in the road”. More direct disclosure of these and other hurdles would have led to open season by short side hedge funds to trade and crush the stock over the now longer than 10 year period which would have caused bankruptcy. Preventing bankruptcy is primary and above all else fiduciary duty and Linda’s moves in this regard with silence are easily defended as what kept the company from going bankrupt while also maintaining investor control of the company. Big picture!; ).
I learned long ago that investors are doing so at their own risk and that they are not entitled to all that they think they are with regard to business affairs. This is why the bears attack management because trusting management to some degree is inherent to any longer term investment decision. Traders don’t need to trust as much as they just trade shorter, fairly predictable cycles. Best wishes.
You have seen what the bad actors did with the share price without emphasis on disclosure that manufacturing and product release hurdles had to be overcome and that there was no known timeline for that. This was hinted at of course in the mandatory disclosures which is all that is required by law. Mr. Neil Woodford called that a “bump in the road”. More direct disclosure of these and other hurdles would have led to open season by short side hedge funds to trade and crush the stock over the now longer than 10 year period which would have caused bankruptcy. Preventing bankruptcy is primary and above all else fiduciary duty and Linda’s moves in this regard with silence are easily defended as what kept the company from going bankrupt while also maintaining investor control of the company. Big picture!; ).
I learned long ago that investors are doing so at their own risk and that they are not entitled to all that they think they are with regard to business affairs. This is why the bears attack management because trusting management to some degree is inherent to any longer term investment decision. Traders don’t need to trust as much as they just trade shorter, fairly predictable cycles. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
